Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1999
06/03/1999WO1999026653A1 Dna vaccines against tick-borne flaviviruses
06/03/1999WO1999026651A1 ribH
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026647A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026634A1 Transcription factor decoy and tumor growth inhibitor
06/03/1999WO1999026479A1 Biocontrol agents for control of root diseases
06/03/1999WO1999026475A1 ribG
06/03/1999WO1999026467A1 Solid matrix conditioning of seeds
06/03/1999WO1999026463A2 Tnf ligand family gene
06/03/1999WO1999019488A9 Novel human egf receptors and use thereof
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999015638B1 Rapid thermal cycle processing methods and apparatus
06/03/1999WO1999015563A9 Catalytic antibodies and a method of producing same
06/03/1999WO1999014353A3 Intrabody-mediated control of immune reactions
06/03/1999WO1999014336A3 Thermostable luciferases and methods of production
06/03/1999WO1999014333A3 Improved method of production of pneumococcal surface proteins
06/03/1999WO1999014313A3 Biological systems for manufacture of polyhydroxylalkanoate polymers containing 4-hydroxyacids
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013907A3 Methods to improve immunogenicity of antigens and specificity of antibodies
06/03/1999WO1999013077A3 Inducible methods for repressing gene function
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999010535A9 A process to study changes in gene expression in stem cells
06/03/1999WO1999009199A3 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
06/03/1999WO1999009166A3 Prostate tumor polynucleotide and antigen compositions
06/03/1999WO1999007841A3 Regulatory mutants of adp-glucose pyrophosphorylase and related compositions and methods
06/03/1999WO1999006565A3 Antifreeze proteins, dna and expression systems
06/03/1999WO1999006552B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN
06/03/1999WO1999006551B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
06/03/1999WO1999006550B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
06/03/1999WO1999006548B1 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS
06/03/1999WO1999003993A3 Suppressors of cytokine signaling; related reagents
06/03/1999WO1998058957A9 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
06/03/1999WO1998037089A8 Matrix derived anti-hiv peptides and transdominant proteins
06/03/1999CA2641217A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2592380A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311759A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999CA2311683A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2311642A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
06/03/1999CA2311632A1 Method and compositions useful for the activation of silent transgenes
06/03/1999CA2311610A1 Human irak-2, a human interleukin-1 receptor associated kinase-2
06/03/1999CA2311472A1 Desaturase genes and their use
06/03/1999CA2311346A1 Solid matrix conditioning of seeds
06/03/1999CA2311237A1 Human proteins having transmembrane domains and dnas encoding these proteins
06/03/1999CA2311170A1 The nip3 family of proteins
06/03/1999CA2311164A1 Nucleic acid ligands of tissue target
06/03/1999CA2310987A1 Tnf ligand family gene
06/03/1999CA2310892A1 Chemokine alpha-5
06/03/1999CA2310808A1 Method of parallel screening for insertion mutants and a kit to perform this method
06/03/1999CA2310621A1 Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
06/03/1999CA2310565A1 Human protein kinase and kinase inhibitors
06/03/1999CA2310561A1 Virulence-associated nucleic acid sequences and uses thereof
06/03/1999CA2310540A1 Human cdc10 homolog
06/03/1999CA2310217A1 Extracellular matrix-binding proteins from staphylococcus aureus
06/03/1999CA2310214A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2309897A1 A novel egf motif protein obtained from a cdna library of fetal liver-spleen
06/03/1999CA2309888A1 Decreasing cell proliferation by decreasing levels of pp5
06/03/1999CA2309884A1 Biocontrol agents for control of root diseases
06/03/1999CA2309809A1 Histamine and serotonin binding molecules
06/03/1999CA2309808A1 A pathogen and stress-responsive promoter for gene expression
06/03/1999CA2309782A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2309781A1 Gram-positive microorganism formate transporters
06/03/1999CA2309718A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2309677A1 Novel gene and protein expressed in neural and pancreatic tissues
06/03/1999CA2309624A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309001A1 Methods and means for modification of glucosinolates in plants
06/03/1999CA2307846A1 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/03/1999CA2253633A1 Complex specific antibodies, method of preparation and uses thereof
06/03/1999CA2252971A1 Soybean adp ribosylation factor
06/02/1999EP0919633A2 Detection of Neisseria Gonorrhoeae by amplification and detection of its nucleic acid
06/02/1999EP0919627A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919626A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919625A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919624A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919623A2 Procedure and kit for cloning of DNA fragments
06/02/1999EP0919622A2 Surface expression of enzyme in gene directed prodrug therapy
06/02/1999EP0919621A1 Human taki dna encoding the same
06/02/1999EP0919620A2 TRAILLK-3: a member of the TNF ligand family
06/02/1999EP0919619A2 Optimizing cells for endogenous gene activation
06/02/1999EP0919618A1 Active Hedgehog protein mutants, methods of production and application
06/02/1999EP0919617A1 Anti-human mp52 monoclonal antibody
06/02/1999EP0919568A1 Escape mutant of the surface antigen of hepatitis B virus
06/02/1999EP0919566A2 Antimicrobial peptides and their use against plant pathogens
06/02/1999EP0919565A2 Labeled oligonucleotides
06/02/1999EP0919122A1 Hepatitis c model animals
06/02/1999EP0919121A1 In vivo electroporation method for early animal embryo
06/02/1999EP0918885A1 Nanoparticles having oligonucleotides attached thereto and uses therefor
06/02/1999EP0918883A2 Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification
06/02/1999EP0918882A1 Regulation of apoptosis and in vitro model for studies thereof
06/02/1999EP0918877A1 Methods for isolating nucleic acids using alkaline protease
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918873A1 Peptide with inhibitory activity towards plant pathogenic fungi
06/02/1999EP0918872A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
06/02/1999EP0918871A2 Afc1 and rce1:isoprenylated caax processing enzymes
06/02/1999EP0918870A1 Chitinase materials and methods
06/02/1999EP0918869A1 Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants
06/02/1999EP0918867A2 Substrate trapping protein tyrosine phosphatases
1 ... 3394 3395 3396 3397 3398 3399 3400 3401 3402 3403 3404 3405 3406 3407 3408 3409 3410 3411 3412 3413 3414 ... 4023